NOW AVAILABLE:
Easier access and expanded coverage
for VASCEPA® (icosapent ethyl)
VASCEPA is now the
exclusive icosapent ethyl
(IPE) for >70% of the Medicare Part D IPE market nationally.
Medicare Part D plans where VASCEPA is PREFERRED or EXCLUSIVE can be found below:
| PLAN NAME | SEGMENT | FORMULARY STATUS |
|---|---|---|
| Aetna Health Plans | Medicare Part D | Covered, Unrestricted, Exclusive IPE |
| Anthem Plans | Medicare Part D | Covered, Unrestricted, Exclusive IPE |
| CVS Health (SilverScript) | Medicare Part D | Covered, Unrestricted, Exclusive IPE |
| Healthfirst | Medicare Part D | Covered, Unrestricted, Exclusive OM-3 |
| Humana Health Plans | Medicare Part D | Preferred, Unrestricted, Exclusive IPE |
| UnitedHealthcare / AARP | Medicare Part D | Preferred, Unrestricted, Exclusive IPE |
| WellCare Plans | Medicare Part D | Covered, Unrestricted, Exclusive OM-3 |
IPE=icosapent ethyl; OM-3=omega-3.
One of the largest Medicare Part D plans in the country, representing 19% of the Medicare Part D population, has moved VASCEPA to Exclusive IPE and Preferred OM-3 status. If generic IPE is rejected, re-run with branded VASCEPA.
Formulary status for VASCEPA® (icosapent ethyl)
VASCEPA is available with a generic copay for your patients
Commercial plans where VASCEPA is available for a generic copay:
| PLAN NAME | SEGMENT | FORMULARY STATUS |
|---|---|---|
| CVS Caremark | Commercial | Covered, Unrestricted, Exclusive IPE |
| Prime Therapeutics AL, FL, IL, KS, NC, NE, NM, OK, TX | Commercial | Generic copay, Exclusive IPE, Some plans may require a PA |
| Aetna | Commercial | Generic copay, Unrestricted |
| MedImpact | Commercial | Preferred, Generic copay, Unrestricted |
| Elixir | Commercial | Generic copay, Unrestricted |
| Navitus | Commercial | Preferred, Generic copay, Unrestricted, Exclusive IPE |
Decision Resources Group database as of November 2023.
